ArborGen Holdings Limited logo

RBC – ArborGen Greenhouse Approved for L3 Quarantine

Regulatory1 July 2019ARBIndustrials

Page 1














Media Contact

Greg Mann

General Manager

ArborGen Australasia

021 871 814

greg.mann@arborgen.co.nz


Rubicon announces ArborGen Greenhouse Receives Approval to

Operate as Level 3 Quarantine Facility


Approval will accelerate importation of new plant varieties for New Zealand Horticulture Growers

2 July 2019 – Rubicon announced today that its wholly owned subsidiary, ArborGen Inc

(“ArborGen”), had received approval from the Ministry of Primary Industries (“MPI”) to operate its

post-entry quarantine greenhouse facility in Te Teko, New Zealand at Level 3. This is the first

privately-owned facility in the country to receive this level of accreditation. Receipt of the approval

will expand ArborGen’s ability to expand its business with the New Zealand horticultural industry to

import new, high performing plant varieties into the country.

ArborGen Australasia General Manager Greg Mann said, “A lack of quarantine capacity has been a

major barrier for New Zealand fruit companies seeking to import and commercialise new genetics

and innovative plant varieties. This newly approved Level 3 quarantine greenhouse capacity will

complement our existing Level 3 Tissue Culture laboratory and assist in achieving New Zealand’s goal

for increasing horticultural exports.”

Quarantine is the process of inspection, testing, and surveillance of new plant material as it crosses

the border into New Zealand. Material is securely held and tested for six to nine months before

receiving approval to be released to commercial growers. This approval was received after a

comprehensive review by MPI of ArborGen’s greenhouse facility, personnel, and operating

procedures.

ArborGen is the world’s largest producer and seller of improved genetics planting material for forest

owners, growing more than 400 million seedlings in the south-eastern United States, Brazil, New

Zealand, and Australia. The company owns six nurseries in Australasia.

Page 2

Mr. Mann said, “Forestry is our core business, but we can use the assets and plant-growing skills we

have to grow a range of high-value horticultural species such as hops, blueberries and strawberries.

We have been working with horticultural companies for some time to the extent regulations have

allowed, but this new Level 3 quarantine accreditation from MPI now means that we can offer New

Zealand importers a one-stop shop, doing everything from providing quarantine services, true to

type testing, maintaining parental stock and ultimately, producing plants for growers, all on one

secure site.”



ArborGen

ArborGen is the largest global supplier of tree seedling products and the leading provider of advanced genetics

for the forest industry. Employing state-of-the-art research, ArborGen is developing high-value products that

significantly improve the productivity of a given acre of land by enabling our customers to grow trees that yield

more wood per acre with greater consistency and quality in a shorter period of time. For more information,

please visit our website at www.arborgen.co.nz.

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.

  • PHL — Promisia Healthcare Limited: 2018 Annual report – printed version to shareholders
    2019-05-02

    PRŌMISIA ANNUAL REPORT 2018 04 Australia The launch of Arthrem in New South Wales in February 2018 coincided with the Medsafe Alert. Sales were affected as pharmacies were reluctant to recommend Arthrem. The combination of a lack of revenue from the New Zealand market and t…”

  • CVT — Comvita Limited: 2019 Annual Report
    2019-09-18

    N O . 4 N O . 5 In thousands of New Zealand dollars 30-Jun-1930-Jun-1830-Jun-17 15 MONTHS 30-Jun-1631-Mar-15 Operating revenue171,104178,493155,879230,743152,702 Operating revenue growth(4)%15%(32)%51%32% Export revenue %80%79%77%76%68% Gross profit63,76273,19562,141117,31171,…”

  • SEK — Seeka Limited: Seeka provides investor presentations
    2019-04-08

    7 $116m $142m $191m $187m $204m $11.3m $13.9m $24.8m $23.1m $26.2m Higher kiwifruit volumes Hayward green up 23% SunGold up 24% 21.4m 27.8m 32.4m 25.7m 31.4m 20142015201620172018 1. Includes insurance proceeds of $3.6m 2. Pcp is previous corresponding per…”